The treatment of coronary heart disease: An update - Part 1: An overview of the risk factors for cardiovascular disease

被引:32
作者
Elisaf, M [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
risk factors; hypertension; diabetes mellitus; dyslipidemia; obesity;
D O I
10.1185/03007990152005414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the main cause of death. Atherosclerosis of coronary arteries is responsible for almost all cases of CVD. The term 'risk factor' describes all those characteristics found in healthy individuals that are independently related to subsequent development of CVD. It includes modifiable biochemical and physiological characteristics, such as hypercholesterolaemia, hypertension, cigarette smoking, diabetes mellitus, obesity and low HDL cholesterol levels, as well as non-modifiable personal characteristics, such as age, gender and family or personal history of early onset CVD. In addition to the 'classic' risk factors mentioned above, several other variables have been implicated as predictors of CVD: left ventricular hypertrophy; infectious agents; markers of inflammation; oxidative stress; and increased levels of fibrinogen, triglycerides, homocysteine and Lp(a)l. However, controversy exists regarding the exact role of these variables in the pathogenesis of atherosclerosis. Furthermore, there are no conclusive data showing that the modification of these variables is associated with a decrease in the incidence of cardiovascular events. Nevertheless, these 'new' risk factors should be taken into account in patients with CVD without established risk factors.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 139 条
[41]   LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B AND LIPOPROTEIN-(A) ABNORMALITIES IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, J ;
MCNAMARA, JR ;
ORDOVAS, JM ;
JENNER, JL ;
SILBERMAN, SR ;
ANDERSON, KM ;
WILSON, PWF ;
SALEM, DN ;
SCHAEFER, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :792-802
[42]   A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].
Gent, M ;
Beaumont, D ;
Blanchard, J ;
Bousser, MG ;
Coffman, J ;
Easton, JD ;
Hampton, JR ;
Harker, LA ;
Janzon, L ;
Kusmierek, JJE ;
Panak, E ;
Roberts, RS ;
Shannon, JS ;
Sicurella, J ;
Tognoni, G ;
Topol, EJ ;
Verstraete, M ;
Warlow, C .
LANCET, 1996, 348 (9038) :1329-1339
[43]  
Ghali Jalal K. 3rd, 1997, Am J Geriatr Cardiol, V6, P38
[44]  
Goldbourt U, 1998, EUR HEART J, V19, pH42
[45]   Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension - Comparison of six antihypertensive agents [J].
Gottdiener, JS ;
Reda, DJ ;
Massie, BM ;
Materson, BJ ;
Williams, DW ;
Anderson, RJ .
CIRCULATION, 1997, 95 (08) :2007-2014
[46]   Plasma homocysteine as a risk factor for vascular disease - The European concerted action project [J].
Graham, IM ;
Daly, LE ;
Refsum, HM ;
Robinson, K ;
Brattstrom, LE ;
Ueland, PM ;
PalmaReis, RJ ;
Boers, GHJ ;
Sheahan, RG ;
Israelsson, B ;
Uiterwaal, CS ;
Meleady, R ;
McMaster, D ;
Verhoef, P ;
Witteman, J ;
Rubba, P ;
Bellet, H ;
Wautrecht, JC ;
deValk, HW ;
Luis, ACS ;
ParrotRoulaud, FM ;
Tan, KS ;
Higgins, I ;
Garcon, D ;
Medrano, MJ ;
Candito, M ;
Evans, AE ;
Andria, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1775-1781
[47]  
GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015
[48]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[49]   Potential new cardiovascular risk factors: Left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen [J].
Harjai, KJ .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (05) :376-386
[50]   RECENT-EVIDENCE ON DRUG-THERAPY OF MILD TO MODERATE HYPERTENSION AND DECREASED RISK OF CORONARY HEART-DISEASE [J].
HEBERT, PR ;
MOSER, M ;
MAYER, J ;
Glynn, RJ ;
HENNEKENS, CH .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (05) :578-581